Mark G. Evans

2.1k citations
79 papers · 1.3k indexed · h-index 17

Mark G. Evans

69 papers receiving 1.2k citations

Peers

Mark G. Evans
Comparison fields: 5 of 111
  • Rheumatology 285
  • Pharmacology 228
  • Immunology 233
  • Small Animals 65
  • Equine 14
Replace I Yaron with:
I Yaron Israel
MARJORIE E. SVOBODA United States
Łukasz A. Poniatowski Poland
Joerg Buddenkotte United States
Piotr Wojdasiewicz Poland
B.B. Saxena United States
David T. Crawford United States
Bin Ma China
Anthony N. Corps United Kingdom
Motoyuki Mihara Japan
Mark G. Evans relative to I Yaron Israel I Yaron's profile →
Citations per field
00.5×5.9×
I Yaron · 1×
Citations per year

Countries citing papers authored by Mark G. Evans

Since Specialization
Citations

This map shows the geographic impact of Mark G. Evans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark G. Evans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark G. Evans more than expected).

Fields of papers citing papers by Mark G. Evans

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark G. Evans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark G. Evans. The network helps show where Mark G. Evans may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Mark G. Evans, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark G. Evans Line = papers co-authored together Mark G. Evans links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20251
2 20242
3 20230
4 20232
5 20221
6 20221
7 202017
8 20191
9 201511
10 20141
11 20139
12 201342
13 20052
14 19959
15 199111
16 199021
17 19884
18 198821
19 198812
20 198258

About Mark G. Evans

Mark G. Evans is a scholar working on Gastroenterology, Ophthalmology, Surgery, Pulmonary and Respiratory Medicine and Cancer Research, having authored 79 papers that have together received 1.3k indexed citations. Recurring topics across this work include Congenital Diaphragmatic Hernia Studies (6 papers), Neuroendocrine Tumor Research Advances (4 papers), Lymphoma Diagnosis and Treatment (4 papers), Breast Implant and Reconstruction (4 papers), Pain Mechanisms and Treatments (4 papers), Retinal Development and Disorders (4 papers), Pancreatic function and diabetes (4 papers) and Glaucoma and retinal disorders (3 papers). The work is most often cited by research in Rheumatology (285 citations), Pharmacology (228 citations), Immunology (233 citations), Small Animals (65 citations) and Equine (14 citations). Mark G. Evans has collaborated with scholars based in United States, Canada and Germany. Frequent co-authors include Roberto E. Guzman, Susan E. Bove, Kenneth S. Kilgore, David I. Watkins, Norman L. Letvin, Thomas F. Tedder, Austin L. Hughes, Zheng W. Chen, Garth L. Warnock and R. Theodore Fletcher. Their work appears in journals such as Veterinary Pathology, Toxicologic Pathology, Journal of Pediatric Surgery, Modern Pathology and Toxicological Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026